- Home
- ALGS vs NMTC Comparison
ALGS vs NMTC Comparison
Compare ALGS & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- NMTC
- Stock Information
- Founded
- ALGS 2018
- NMTC 2009
- Country
- ALGS United States
- NMTC United States
- Employees
- ALGS N/A
- NMTC N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- NMTC Medical/Dental Instruments
- Sector
- ALGS Health Care
- NMTC Health Care
- Exchange
- ALGS Nasdaq
- NMTC Nasdaq
- Market Cap
- ALGS 23.5M
- NMTC 27.7M
- IPO Year
- ALGS 2020
- NMTC N/A
- Fundamental
- Price
- ALGS $19.17
- NMTC $0.71
- Analyst Decision
- ALGS Strong Buy
- NMTC
- Analyst Count
- ALGS 1
- NMTC 0
- Target Price
- ALGS $75.00
- NMTC N/A
- AVG Volume (30 Days)
- ALGS 476.7K
- NMTC 112.9K
- Earning Date
- ALGS 11-06-2024
- NMTC 12-12-2024
- Dividend Yield
- ALGS N/A
- NMTC N/A
- EPS Growth
- ALGS N/A
- NMTC N/A
- EPS
- ALGS N/A
- NMTC N/A
- Revenue
- ALGS $5,997,000.00
- NMTC $3,922,499.00
- Revenue This Year
- ALGS N/A
- NMTC $109.53
- Revenue Next Year
- ALGS N/A
- NMTC $90.00
- P/E Ratio
- ALGS N/A
- NMTC N/A
- Revenue Growth
- ALGS N/A
- NMTC N/A
- 52 Week Low
- ALGS $6.76
- NMTC $0.60
- 52 Week High
- ALGS $30.00
- NMTC $2.00
- Technical
- Relative Strength Index (RSI)
- ALGS 82.79
- NMTC 28.75
- Support Level
- ALGS $15.66
- NMTC $0.83
- Resistance Level
- ALGS $21.89
- NMTC $0.94
- Average True Range (ATR)
- ALGS 2.25
- NMTC 0.07
- MACD
- ALGS 1.24
- NMTC -0.02
- Stochastic Oscillator
- ALGS 79.79
- NMTC 8.61
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.